These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30340138)

  • 1. Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells.
    Russo V; Paciocco A; Affinito A; Roscigno G; Fiore D; Palma F; Galasso M; Volinia S; Fiorelli A; Esposito CL; Nuzzo S; Inghirami G; de Franciscis V; Condorelli G
    Mol Ther Nucleic Acids; 2018 Dec; 13():334-346. PubMed ID: 30340138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axl-Targeted Delivery of the Oncosuppressor miR-137 in Non-small-Cell Lung Cancer.
    Nuzzo S; Catuogno S; Capuozzo M; Fiorelli A; Swiderski P; Boccella S; de Nigris F; Esposito CL
    Mol Ther Nucleic Acids; 2019 Sep; 17():256-263. PubMed ID: 31276956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL.
    Iaboni M; Russo V; Fontanella R; Roscigno G; Fiore D; Donnarumma E; Esposito CL; Quintavalle C; Giangrande PH; de Franciscis V; Condorelli G
    Mol Ther Nucleic Acids; 2016 Mar; 5(3):e289. PubMed ID: 27111415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
    Zhou YL; Xu YJ; Qiao CW
    Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-34c-3p functions as a tumour suppressor by inhibiting eIF4E expression in non-small cell lung cancer.
    Liu F; Wang X; Li J; Gu K; Lv L; Zhang S; Che D; Cao J; Jin S; Yu Y
    Cell Prolif; 2015 Oct; 48(5):582-92. PubMed ID: 26250586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
    Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression.
    Quirico L; Orso F; Esposito CL; Bertone S; Coppo R; Conti L; Catuogno S; Cavallo F; de Franciscis V; Taverna D
    Int J Biol Sci; 2020; 16(7):1238-1251. PubMed ID: 32174798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiRNA-34c Regulates Bovine Sertoli Cell Proliferation, Gene Expression, and Apoptosis by Targeting the
    Sun H; Yu H; Xia L; Jiang P; Bai Z; Gao M; Zhao Z; Yang R; Fang X
    Animals (Basel); 2021 Aug; 11(8):. PubMed ID: 34438849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS.
    Song J; Wang Q; Luo Y; Yuan P; Tang C; Hui Y; Wang Z
    Int J Clin Exp Pathol; 2015; 8(10):12728-37. PubMed ID: 26722462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hmiR-34c-3p upregulation inhibits the proliferation of colon cancer cells by targeting EIF3D.
    Du W; Cheng H; Peng L; Yang D; Yang C
    Anticancer Drugs; 2018 Nov; 29(10):975-982. PubMed ID: 30096129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-34c acts as a tumor suppressor in non-small cell lung cancer by inducing endoplasmic reticulum stress through targeting HMGB1.
    Tu L; Long X; Song W; Lv Z; Zeng H; Wang T; Liu X; Dong J; Xu P
    Onco Targets Ther; 2019; 12():5729-5739. PubMed ID: 31410019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of miR-34c-3p and miR-34c-5p on SiHa cells proliferation apoptosis, migration and invasion.
    López JA; Alvarez-Salas LM
    Biochem Biophys Res Commun; 2011 Jun; 409(3):513-9. PubMed ID: 21600876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of long non-coding RNA SNHG14 protects against acute lung injury induced by lipopolysaccharide through microRNA-34c-3p-dependent inhibition of WISP1.
    Zhu J; Bai J; Wang S; Dong H
    Respir Res; 2019 Oct; 20(1):233. PubMed ID: 31660971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion.
    Zhang H; Zhu X; Li N; Li D; Sha Z; Zheng X; Wang H
    Acta Biochim Biophys Sin (Shanghai); 2015 Jul; 47(7):496-503. PubMed ID: 25998575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-34c inhibits myoblasts proliferation by targeting YY1.
    Wang M; Liu C; Su Y; Zhang K; Zhang Y; Chen M; Ge M; Gu L; Lu T; Li N; Yu Z; Meng Q
    Cell Cycle; 2017 Sep; 16(18):1661-1672. PubMed ID: 28125315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.
    Catuogno S; Cerchia L; Romano G; Pognonec P; Condorelli G; de Franciscis V
    Oncogene; 2013 Jan; 32(3):341-51. PubMed ID: 22370637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.
    Wu J; Li WZ; Huang ML; Wei HL; Wang T; Fan J; Li NL; Ling R
    Biochem Biophys Res Commun; 2017 Jan; 483(1):10-16. PubMed ID: 28069384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
    Xiao P; Liu WL
    Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-educated platelet miR-34c-3p and miR-18a-5p as potential liquid biopsy biomarkers for nasopharyngeal carcinoma diagnosis.
    Wang H; Wei X; Wu B; Su J; Tan W; Yang K
    Cancer Manag Res; 2019; 11():3351-3360. PubMed ID: 31114371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.